Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Food Allergenic Extract [EPC]
Eleuthero (Eleutherococcus senticosus) is a non-standardized plant allergenic extract used primarily in diagnostic medicine to identify hypersensitivity. It belongs to the class of Non-Standardized Plant Allergenic Extracts [EPC].
Name
Eleuthero
Raw Name
ELEUTHERO
Category
Non-Standardized Food Allergenic Extract [EPC]
Drug Count
3
Variant Count
4
Last Verified
February 17, 2026
About Eleuthero
Eleuthero (Eleutherococcus senticosus) is a non-standardized plant allergenic extract used primarily in diagnostic medicine to identify hypersensitivity. It belongs to the class of Non-Standardized Plant Allergenic Extracts [EPC].
Detailed information about Eleuthero
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Eleuthero.
Eleuthero belongs to the Araliaceae family. As a non-standardized extract, its potency is not measured by a specific biological activity unit (such as Bioequivalent Allergy Units) but is instead prepared based on the weight of the raw material relative to the volume of the extracting solvent (w/v ratio) or by Protein Nitrogen Unit (PNU) content. This classification is critical because it highlights the variability inherent in the product; different manufacturers may produce extracts with varying levels of antigenic proteins, necessitating cautious titration and professional oversight.
Historically, the FDA has permitted the use of these extracts under the grandfathering of biological products, provided they meet safety and purity standards. In the clinical setting, Eleuthero extract is utilized by allergists and immunologists to determine if a patient has developed IgE-mediated hypersensitivity to the plant's proteins, which can occur through occupational exposure, dietary ingestion, or environmental contact.
The mechanism of action for Eleuthero as an allergenic extract is rooted in the fundamental principles of Type I Hypersensitivity (immediate hypersensitivity). When the extract is introduced into the skin via a skin prick test (SPT) or intradermal injection, the specific allergenic proteins within the Eleuthero extract encounter sensitized mast cells.
At the molecular level, if a patient is allergic, their immune system has previously produced specific Immunoglobulin E (IgE) antibodies that are 'loaded' onto the surface of mast cells and basophils via high-affinity receptors (FcεRI). The Eleuthero antigens cross-link these surface-bound IgE molecules. This cross-linking triggers a signal transduction cascade involving tyrosine kinases, leading to the degranulation of the mast cell. This process releases pre-formed inflammatory mediators, most notably histamine, leukotrienes, and prostaglandins.
In a diagnostic setting, this release causes localized vasodilation (redness or 'flare') and increased capillary permeability (swelling or 'wheal'). The size of the wheal and flare reaction is measured by the clinician to assess the degree of sensitization. For patients undergoing immunotherapy (allergy shots), the mechanism involves the gradual induction of immune tolerance, shifting the immune response from a Th2-dominated (allergic) profile to a Th1 or T-regulatory profile, increasing the production of IgG4 'blocking' antibodies.
Because Eleuthero allergenic extracts are typically administered via the epicutaneous (skin prick) or intradermal route, their pharmacokinetic profile differs significantly from systemic medications.
Eleuthero allergenic extracts are used for the following indications:
Eleuthero extract is generally available in the following specialized forms:
> Important: Only your healthcare provider can determine if Eleuthero is right for your specific condition. These extracts must only be administered by professionals trained in the management of systemic allergic reactions.
Dosage for Eleuthero allergenic extract is highly individualized and depends entirely on the method of administration and the patient's sensitivity level.
For adults, the standard procedure involves applying one drop of the extract (typically at a concentration of 1:10 or 1:20 w/v) to the forearm or back. A sterile lancet is then used to prick the skin through the drop. A positive control (histamine) and a negative control (saline/glycerin) are always used simultaneously for comparison.
If the skin prick test is negative but clinical suspicion remains high, an intradermal test may be performed. The healthcare provider injects 0.02 to 0.05 mL of a much more dilute extract (e.g., 1:1000 w/v) into the dermis to create a small bleb.
If used for desensitization, the dose starts at an extremely low concentration (e.g., 0.1 mL of a 1:100,000 dilution) and is increased weekly or bi-weekly until a maintenance dose is reached. This maintenance dose is often the highest concentration tolerated by the patient without a systemic reaction.
Eleuthero allergenic extracts are not commonly used in pediatric populations unless a specific allergy is suspected.
No specific dosage adjustments are provided for renal impairment because the systemic absorption of the allergenic proteins is negligible. However, patients with severe renal disease may have altered skin reactivity (uremic pruritus), which can interfere with the interpretation of test results.
No dosage adjustments are required for patients with hepatic impairment. The metabolism of allergenic proteins does not rely on hepatic CYP450 pathways.
In patients over 65, skin reactivity may be diminished due to age-related changes in skin turgor and mast cell density. A larger wheal-and-flare threshold or the use of intradermal testing may be necessary if the initial skin prick test is inconclusive.
Eleuthero extracts are never for self-administration. They must be administered in a clinical setting by a qualified healthcare provider.
In the context of diagnostic testing, a missed dose simply means the test must be rescheduled. For patients on an immunotherapy schedule, a missed dose may require 'back-dosing' (reducing the concentration for the next injection) to ensure safety, depending on how much time has elapsed since the last injection.
An 'overdose' in the context of an allergenic extract is defined as the administration of a concentration that triggers a systemic allergic reaction rather than a localized one.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance.
The most frequent side effects of Eleuthero allergenic extract are localized to the site of administration. These are often expected as part of the diagnostic process.
> Warning: Stop taking Eleuthero and call your doctor immediately if you experience any of these symptoms of a systemic allergic reaction.
For diagnostic use, there are no known long-term side effects. For patients receiving long-term immunotherapy, there is a theoretical risk of developing new sensitivities, though this is rare. Prolonged use of allergenic extracts has not been associated with organ toxicity or malignancy.
While specific 'Black Box' warnings for Eleuthero may vary by manufacturer, most allergenic extracts carry a class-wide warning regarding the risk of severe systemic reactions.
Summary of Class Warning:
Report any unusual symptoms to your healthcare provider.
Eleuthero allergenic extract is a potent biological substance. Its use is restricted to diagnostic or therapeutic settings under the supervision of an allergist or immunologist. It is not a nutritional supplement in this form and should never be ingested or used at home.
No specific FDA black box warning is unique to Eleuthero; however, it falls under the general warning for all Non-Standardized Allergenic Extracts. This warning emphasizes that these products can cause anaphylaxis and must be used with extreme caution in patients with respiratory compromise or those taking medications that complicate the treatment of an allergic reaction.
Eleuthero extract itself does not cause sedation. However, if a patient experiences a systemic reaction or is given an antihistamine (like diphenhydramine) to treat a local reaction, they should not drive or operate heavy machinery until the effects have fully worn off.
Alcohol consumption should be avoided on the day of testing. Alcohol can increase peripheral vasodilation, which may potentially enhance the size of a skin test reaction or accelerate the onset of a systemic reaction.
There is no withdrawal syndrome associated with Eleuthero extracts. However, if a patient is undergoing immunotherapy and stops treatment abruptly, they will lose the immune tolerance they have built up and may experience a return of their original allergic symptoms upon exposure to the plant.
> Important: Discuss all your medical conditions with your healthcare provider before starting Eleuthero testing.
There are no direct food interactions with the extract itself. However, patients with a known allergy to other plants in the Araliaceae family (like English Ivy or Ginseng) may show cross-reactivity, which should be considered when interpreting results.
Eleuthero extract administration does not typically interfere with standard blood chemistry or hematology tests. Its primary interaction is with the skin test itself, where it is intended to produce a measurable local reaction.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, especially those for blood pressure or allergies.
Patients allergic to Eleuthero may also react to:
> Important: Your healthcare provider will evaluate your complete medical history before prescribing or administering Eleuthero extract.
Eleuthero allergenic extract is classified as FDA Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women. Animal reproduction studies have not been conducted with allergenic extracts. The primary concern is not direct teratogenicity (birth defects) from the extract, but rather the danger of a systemic allergic reaction in the mother. Anaphylaxis can lead to maternal hypotension and uterine contraction, which can cause fetal hypoxia (lack of oxygen) or miscarriage. Therefore, diagnostic skin testing is generally avoided during pregnancy unless the information is vital for immediate management.
It is not known whether the allergenic proteins from Eleuthero extract are excreted in human milk. However, because the amount used in skin testing is so small and systemic absorption is minimal, it is considered unlikely to affect a nursing infant. Most experts agree that skin testing and continuing maintenance immunotherapy are safe during breastfeeding, but starting a new immunotherapy regimen is often delayed.
Eleuthero extract is safe for use in children, provided the child is old enough to cooperate with the testing procedure.
In patients over 65 years of age, the skin's reactivity to histamine and allergens decreases. This can lead to smaller wheals and potentially false-negative results. Additionally, elderly patients are more likely to have underlying cardiovascular disease or be taking medications like beta-blockers or ACE inhibitors, which increases the complexity of managing a systemic reaction. Clinical judgment is required to determine the safety of testing in this population.
No dosage adjustment is needed for renal impairment. However, clinicians should be aware that patients with end-stage renal disease (ESRD) often have chronic pruritus and altered skin physiology, which can make the interpretation of a wheal-and-flare reaction difficult.
There are no specific considerations for hepatic impairment, as the clearance of these biological proteins does not involve the liver's metabolic pathways.
> Important: Special populations require individualized medical assessment by an allergy specialist.
Eleuthero allergenic extract acts as a source of exogenous antigens. When introduced into the skin, these antigens bind to specific IgE antibodies attached to the surface of mast cells. This triggers the 'allergic cascade.' The primary allergens in Eleuthero are thought to be proteins and glycoproteins within the plant's cellular structure. Unlike pharmacological agents that bind to a single receptor to elicit a therapeutic effect, this extract is a complex mixture designed to provoke a multi-faceted immune response for diagnostic identification.
| Parameter | Value |
|---|---|
| Bioavailability | Negligible (Local administration) |
| Protein Binding | Binds to IgE in tissue |
| Half-life | Local degradation within hours |
| Tmax | 15-20 minutes (for skin reaction) |
| Metabolism | Local Proteolysis |
| Excretion | Lymphatic/Renal (minimal) |
Eleuthero belongs to the Non-Standardized Plant Allergenic Extract class. It is grouped with other botanical extracts like Ragweed, Oak, and Grass extracts used in allergy clinics. Unlike 'Standardized' extracts (like certain Grasses or Dust Mites), Eleuthero does not have a federally mandated potency test, making it essential to use the same manufacturer's product consistently for a single patient.
Common questions about Eleuthero
In a formal clinical setting, Eleuthero extract is primarily used as a diagnostic tool to determine if a patient has an allergy to the *Eleutherococcus senticosus* plant. It is administered by an allergist through a skin prick test or an intradermal injection to observe for a wheal-and-flare reaction. This is different from the over-the-counter herbal supplements used for energy or stress. Doctors use this specific extract to confirm hypersensitivity in patients who may react to herbal products or occupational dust. It is an essential tool for ensuring patient safety before they use botanical products containing this ingredient.
The most common side effects are localized to the area where the skin was pricked or injected. Patients typically experience itching, redness, and a small raised bump called a wheal, which looks similar to a mosquito bite. These symptoms usually appear within 15 minutes and resolve on their own within an hour or two. Some patients may feel slight warmth or tenderness at the site. Because these reactions are the intended result of a positive allergy test, they are generally not considered harmful unless they become very large or are accompanied by systemic symptoms.
It is strongly advised to avoid alcohol on the day you are scheduled for Eleuthero allergy testing. Alcohol causes blood vessels to dilate (expand), which can make a skin reaction appear larger or more severe than it actually is, leading to an inaccurate diagnosis. Furthermore, alcohol can increase the speed at which an allergen enters the bloodstream, potentially increasing the risk of a systemic reaction. You should wait at least 24 hours after your test before consuming alcohol. Always follow the specific pre-test instructions provided by your allergy clinic.
Allergy testing with Eleuthero is generally avoided during pregnancy as a precautionary measure. While the extract itself is not known to cause birth defects, the risk lies in the possibility of a severe allergic reaction (anaphylaxis) during the test. Anaphylaxis can cause a dangerous drop in the mother's blood pressure and reduce the oxygen supply to the baby. Most allergists recommend waiting until after delivery to perform diagnostic skin tests. If you are already on immunotherapy (allergy shots) and become pregnant, your doctor may allow you to continue at a stable dose, but they will rarely start a new treatment.
When used for diagnostic skin testing, the reaction to Eleuthero is almost immediate. The healthcare provider will typically prick the skin and then wait exactly 15 to 20 minutes to read the results. If a person is allergic, the wheal (bump) and flare (redness) will reach its maximum size during this window. If used for immunotherapy (allergy shots), it takes much longer to see a benefit. Patients usually require several months of weekly injections before their immune system begins to develop a tolerance to the allergen and symptoms begin to decrease.
Since Eleuthero extract is usually administered as a one-time diagnostic test, 'stopping' it is not typically an issue. However, if you are receiving Eleuthero as part of an immunotherapy (allergy shot) program, stopping suddenly will result in the loss of the allergic tolerance you have built up. You will not experience 'withdrawal' symptoms like you might with some medications, but your allergy symptoms will likely return when you are exposed to the plant again. If you need to stop your allergy shots, you should discuss a plan with your allergist to ensure your symptoms remain managed.
If you miss an appointment for an Eleuthero skin test, you simply need to reschedule it with your doctor. If you are in the middle of an immunotherapy schedule and miss an injection, contact your allergist immediately. Depending on how many days or weeks have passed since your last shot, the doctor may need to reduce the dose of your next injection to ensure it is safe. Missing multiple doses may require you to restart the 'build-up' phase of your treatment. Consistency is key to the success and safety of allergy desensitization.
There is no clinical evidence to suggest that Eleuthero allergenic extract causes weight gain. The amount of extract used in diagnostic testing or even in long-term immunotherapy is extremely small and does not contain enough calories or metabolic-altering compounds to affect body weight. Unlike certain medications like systemic corticosteroids or some antidepressants, allergenic extracts do not influence appetite or fat storage. If you experience unexpected weight gain while undergoing allergy treatment, you should consult your primary care physician to investigate other potential causes.
Eleuthero extract can interact with several types of medications, particularly those that affect the immune system or the heart. Antihistamines will block the skin's reaction, leading to a false-negative test result, so they must be stopped several days before testing. More seriously, beta-blockers used for blood pressure can make it very difficult for doctors to treat you if you have a severe allergic reaction to the test. You must provide your allergist with a complete list of all medications, including over-the-counter drugs and supplements, before undergoing any testing with Eleuthero.
The term 'generic' is not typically used for allergenic extracts in the same way it is for pills. Instead, Eleuthero is available as a 'non-standardized extract' from various specialized biological manufacturers. Because these extracts are non-standardized, one manufacturer's version may be slightly stronger or weaker than another's. Therefore, once a doctor starts a patient on a specific brand for immunotherapy, they usually try to stay with that same brand to ensure the dosage remains consistent and safe. You cannot simply swap one brand for another without medical supervision.